Investigating Botulinum Toxin A on the Functional Properties of the Prostate

European Urology

Volumn 52, Issue 2, 2007, Pages 324-325

  Choo, Myung Soo ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; BOTULINUM TOXIN A; CHOLINESTERASE; DOPAMINE; GLYCINE; MUSCARINIC RECEPTOR; NITRIC OXIDE; NORADRENALIN; SEROTONIN; STEROID 5ALPHA REDUCTASE;

BLADDER NECK STENOSIS; BLEPHAROSPASM; DOSE RESPONSE; DYSTONIA; EDITORIAL; ELECTROPHYSIOLOGY; ESOPHAGUS ACHALASIA; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MICTURITION DISORDER; NEUROGENIC BLADDER; NEUROMUSCULAR DISEASE; NEUROMUSCULAR TRANSMISSION; NONHUMAN; PARASYMPATHETIC INNERVATION; PRIORITY JOURNAL; PROSTATE; PROSTATE HYPERTROPHY; STRABISMUS; URODYNAMICS;

ANIMALS; BOTULINUM TOXIN TYPE A; DISEASE MODELS, ANIMAL; DOGS; HUMANS; MALE; NEUROMUSCULAR AGENTS; PROSTATE; PROSTATIC DISEASES; TENSILE STRENGTH;

EID: 34250762688     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.03.030     Document Type: Editorial

References (10)

1. Horsfall D.J., Mayne K., and Ricciardelli C. Age-related changes in guinea pig prostatic stroma. Lab Invest 70 (1994) 753-763
2. Lowseth L.A., Gerlach R.F., Gillett N.A., and Muggenburg B.A. Age-related changes in the prostate and testes of the beagle dog. Vet Pathol 27 (1990) 347-353
3. Lepor H., Zhang W., Kobayashi S., Tang R., Wang B., and Shapiro E. A comparison of the binding and functional properties of alpha-1 adrenoceptors and area density of smooth muscle in the human, canine and rat prostates. J Pharmacol Exp Ther 270 (1994) 722-727
4. Fernandez J.L., Rivera L., Lopez P.G., Recio P., Vela-Navarrett R., and Garcia-Sacristan A. Characterization of the muscarinic receptor mediating contraction of the dog prostate. J Auton Pharmacol 18 (1998) 205-211
5. MacKenzie I., Burnstock G., and Dolly J.O. The effects of purified botulinum neurotoxin type A on cholinergic, adrenergic and non-adrenergic, atropine-resistant autonomic neuromuscular transmission. Neuroscience 7 (1982) 997-1006
6. Jankovic J., and Brin M.F. Therapeutic uses of botulinum toxin. N Engl J Med 324 (1991) 1186-1194
7. Smith C.P., and Chancellor M.B. Emerging role of botulinum toxin in the treatment of voiding dysfunction. J Urol 171 (2004) 2128-2137
8. Maria G., Brisinda G., Civello I.M., Bentivoglio A.R., Sganga G., and Albanese A. Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study. Urology 62 (2003) 259-264
9. Chuang Y.C., Huang C.C., Kang H.Y., et al. Novel action of botulinum toxin on the stromal and epithelial components of prostate gland. J Urol 173 (2006) 1158-1163
10. Lin A.T.L., Yang A.H., and Chen K.-K. Effects of botulinum toxin A on the contractile function of dog prostate. Eur Urol. 52 (2007) 582-589